Trial Profile
Ancillary Effects of Oral Naloxegol (Movantik)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Sep 2023
Price :
$35
*
At a glance
- Drugs Naloxegol (Primary)
- Indications Constipation
- Focus Adverse reactions
- 14 Aug 2023 Status changed from active, no longer recruiting to completed.
- 09 Dec 2021 Planned End Date changed from 31 Oct 2021 to 28 Feb 2022.
- 28 Apr 2021 Planned End Date changed from 31 Mar 2021 to 31 Oct 2021.